An infant Motrin recall is still in effect, reports CNN Health on Oct. 7. The recall was initiated last month by McNeil Consumer Healthcare, makers of the drug Motrin, and they have announced that the recall still remains in place one month later.
On September 6, the FDA carried the recall alert:
“After releasing these three lots of Concentrated MOTRIN® Infants’ Drops Original Berry Flavor 1/2 fl oz into the market, tiny plastic particles (approximately 1 mm in size or about the size of a poppy seed) were identified in a different product lot during manufacturing. This lot was not released to the market.”
The consumer alert says that the particles originated in a shipment from a third party supplier of ibuprofen, but that “out of an abundance of caution, McNeil is voluntarily recalling the three lots released to the market made with the same batch of active ingredient.”
According to McNeil, the “potential for adverse medical events related to the reason for this recall is not likely.”
The following lots remain recalled: DCB3T01, DDB4R01 and DDB4S01.
Approximately 200,000 bottles were subject to the initial recall. Children’s or Adult MOTRIN products were not included in this recall, and full 1 fluid ounce size Infant Drops were also unaffected.
CNN says that consumers with questions or who would like to request a refund may call the company at 1-877-414-7709.